Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR : Nature : Nature Publishing Group - http://www.nature.com/nature...
Mar 11, 2012
from
Colon cancer patients harbouring BRAF(V600E) oncogenic lesion have poor prognosis and show only a very limited response to vemurafenib, despite it being effective for melanoma. Why?
- Sally Church